About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Chicago | 383 Studies

Clinical Trials Prostate CancerChicago

Prostate Cancer Clinical Trials in Chicago

Find 383 clinical trials for prostate cancer near Chicago, Illinois. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 221-240 of 383 trials

CompletedAbiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyThis is a phase 3 study to compare the clinical benefit of abiraterone acetate plus prednisone with placebo plus prednisone in patients with metastatic castration-resistant…NCT00638690·Birmingham, Alabama and 126 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedAndrogen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate CancerThis phase II trial studies how well androgen deprivation therapy and vorinostat followed by radical prostatectomy works in treating patients with prostate cancer that has not…NCT00589472·Los Angeles, California and 14 others

CompletedStudy to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates a histopathologic Gleason Score of ≤…NCT02615067·Duarte, California and 44 others

UnknownLycopene in Preventing Prostate Cancer in Healthy ParticipantsRATIONALE: Chemoprevention is the use of certain drugs or substances to keep cancer from forming, growing, or coming back.NCT00322114·Chicago, Illinois

Active not recruitingPhase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)The main objective of the study is to compare overall survival in participants receiving xaluritamig versus investigator's choice (cabazitaxel or second androgen receptor-directed…NCT06691984·Birmingham, Alabama and 163 others

CompletedMagnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate CancerThis study is being done to help researchers understand more about prostate cancer that has spread to the bones by using the newest magnetic resonance imaging (MRI) techniques and…NCT01599793·Chicago, Illinois

RecruitingSafety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate CancerThere are many treatment options for men with various stages of prostate cancer. Some treatments work well for a while but can cause medical problems in some men.NCT05997615·Duarte, California and 23 others

RecruitingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryInternational registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool…NCT03452774·Birmingham, Alabama and 67 others

CompletedEffect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone TreatmentsThe purpose of this study is to learn how an educational intervention about orchiectomy as an alternative to medical castration for those who are already on medical castration…NCT04705038·Chicago, Illinois

TerminatedA Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate CancerThe purpose of this study is to assess the safety, efficacy, tolerability, and toxicity of docetaxel alone, in combination with BMS-986218, or in combination with nivolumab plus…NCT05169684·Tucson, Arizona and 30 others

TerminatedStudy of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)The purpose of this study is to assess the efficacy and safety of the combination of pembrolizumab (MK-3475) and enzalutamide in the treatment of men with metastatic…NCT03834493·Mobile, Alabama and 258 others

RecruitingPSMA PET for Surveillance After Focal TherapyThis study is about adding PSMA PET (Prostate Specific Membrane Antigen- Positron Emission Tomography) to routine magnetic resonance imaging (MRI) scans to help detect prostate…NCT07115914·Chicago, Illinois

CompletedBlood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid TumorsThe primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay…NCT03662204·Phoenix, Arizona and 118 others

CompletedPReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2Approximately one million transrectal prostate biopsies are performed annually in the U.S., and the risk of post- biopsy infection is increasing due to greater antibiotic…NCT04815876·Los Angeles, California and 15 others

CompletedRelative Bioavailability Study of Enzalutamide in Prostate Cancer PatientsA multiple dose relative bioavailability study in patients with prostate cancer comparing a capsule and a tablet formulation of enzalutamide.NCT01902251·Denver, Colorado and 3 others

Active not recruitingCeralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid TumorsThis phase II trial studies how well ceralasertib, am Ataxia telangiectasia and Rad3-related (ATR) kinase inhibitor, works alone or in combination with olaparib or durvalumab in…NCT03682289·Duarte, California and 2 others

CompletedHormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate CancerRATIONALE: Androgens can stimulate the growth of prostate cancer cells. Drugs such as ketoconazole may stop the production of androgens.NCT00027859·Huntsville, Alabama and 97 others

CompletedEMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate CancerThe primary objective of the trial is to evaluate the clinical anti-tumor activity of EMD 525797 administered as 1-hour intravenous infusion every 3 weeks in terms of progression…NCT01360840·Pleasant Hill, California and 70 others

Active not recruitingA Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPCThe purpose of this study is to determine if the addition of apalutamide to ADT provides superior efficacy in improving radiographic progression-free survival (rPFS) or overall…NCT02489318·Homewood, Alabama and 219 others

CompletedCombination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005810·San Francisco, California and 6 others

PreviousPage 12 of 20Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma